CD8A and neoplasm: Mechanistically, TLS enhance T-cell-mediated antitumor immunity by supporting CD8+ T cell differentiation into effector memory T cells and driving Th1-type cytokine secretion, like IFN-γ, TNF-α, as demonstrated by transcriptional profiling of tumor-infiltrating lymphocytes (30).